Endologix Grabs IDE for Aneurysm Sealing Protocol

The FDA granted Endologix an investigational device exemption approval for its Nellix Chimney EndoVascular Aneurysm Sealing System (ChEVAS) for treating complex abdominal aortic aneurysms.

The system, an endovascular AAA treatment, is designed to join the company’s Nellix 3.5 endograft with parallel visceral stents.

Endovascular aneurysm sealing “will offer innovative new technology to a group of patients that are underserved by the current standard of care,” the devicemaker says.